| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiogenesis, Invasion, and Metastasis Characteristics of Hepatocellular Carcinoma
|
Yüksel, Şirin
|
|
2017
|
48 |
3 |
p. 256-259
|
artikel
|
| 2 |
Barcelona Clinic Liver Cancer (BCLC) Staging: Does It Cover All Our Expectation
|
Sonsuz, Abdullah
|
|
2017
|
48 |
3 |
p. 260-261
|
artikel
|
| 3 |
Cancer Stem Cells in Hepatocellular Carcinoma
|
Yagci, Tamer
|
|
2017
|
48 |
3 |
p. 241-245
|
artikel
|
| 4 |
Enlighting the Shadow for Advanced Hepatocellular Carcinoma: Immunotherapy with Immune Checkpoint Inhibitors
|
Sahin, Berksoy
|
|
2017
|
48 |
3 |
p. 288-290
|
artikel
|
| 5 |
Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology)
|
Ozakyol, Aysegul
|
|
2017
|
48 |
3 |
p. 238-240
|
artikel
|
| 6 |
HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT)
|
Güney, İsa Burak
|
|
2017
|
48 |
3 |
p. 276-280
|
artikel
|
| 7 |
Hepatocellular Cancer: Is Recurrence Inevitable?
|
Doganay, Levent
|
|
2017
|
48 |
3 |
p. 274-275
|
artikel
|
| 8 |
Is That Possible to Stop or Cease the NASH to Turn into HCC?
|
Uygun, Ahmet
|
|
2017
|
48 |
3 |
p. 250-255
|
artikel
|
| 9 |
Liver Transplantation for Hepatocellular Carcinoma at Inonu University
|
Kayaalp, Cuneyt
|
|
2017
|
48 |
3 |
p. 268-271
|
artikel
|
| 10 |
Liver Transplantation for Hepatocellular Carcinoma: “Experience of Memorial Sisli Hospital”
|
Acarlı, Koray
|
|
2017
|
48 |
3 |
p. 272-273
|
artikel
|
| 11 |
Liver Transplantation for Hepatocellular Carcinoma: Kent Hospital Experience
|
Yılmaz, Cahit
|
|
2017
|
48 |
3 |
p. 267
|
artikel
|
| 12 |
Molecular Pathogenesis of Liver Cancer
|
Ozturk, Mehmet
|
|
2017
|
48 |
3 |
p. 222-224
|
artikel
|
| 13 |
New Paradigm: Adaptive Approach
|
Akkız, Hikmet
|
|
2017
|
48 |
3 |
p. 219-221
|
artikel
|
| 14 |
Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others
|
Kantarci, Mecit
|
|
2017
|
48 |
3 |
p. 282-285
|
artikel
|
| 15 |
Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis
|
Yılmaz, Yeliz
|
|
2017
|
48 |
3 |
p. 225-237
|
artikel
|
| 16 |
Surveillance of the Patients with High Risk of Hepatocellular Cancer
|
Örmeci, Necati
|
|
2017
|
48 |
3 |
p. 246-249
|
artikel
|
| 17 |
The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer
|
Oğul, Ali
|
|
2017
|
48 |
3 |
p. 286-287
|
artikel
|
| 18 |
Validation of a Liver Index and Its Significance for HCC Aggressiveness
|
Carr, Brian I.
|
|
2017
|
48 |
3 |
p. 262-266
|
artikel
|
| 19 |
Yttrium-90 (Y-90) Resin Microsphere Therapy for Patients with Unresectable Hepatocellular Carcinoma: a Single-Center Experience
|
İnce, Semra
|
|
2017
|
48 |
3 |
p. 281
|
artikel
|
Tijdschrift beschrijving